Entrada Therapeutics grants 18,600 inducement RSUs to new hires under 2025 equity plan

Entrada Therapeutics

Entrada Therapeutics

TRDA

0.00
  • Entrada Therapeutics granted 18,600 restricted stock units to three newly hired non-executive employees under its 2025 Inducement Equity Plan, effective June 1, 2026.
  • Vesting schedule: 25% on the first anniversary of the vesting start date, then 6.25% quarterly on March 1, June 1, Sept. 1, Dec. 1.
  • Awards vest only if the employee remains in continuous service through each vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606011630PRIMZONEFULLFEED9728554) on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.